HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Diabetes & Endocrinology
Cohort
Combination valsartan and dapagliflozin improves blood pressure and glucose in Type 2 Diabetes and hypertension.
Two Common Heart and Kidney Drugs Work Better Together Than Alone
This retrospective cohort study of 245 patients with coexisting Type 2 Diabetes Mellitus and hypertension found that combination therapy wit…
For patients with diabetes and high blood pressure, combining two common medications may offer stronger protection for the heart and kidneys…
Frontiers
Apr 24, 2026
Psychiatry
Cohort
Scoping review on AI fundus photography for Type 2 Diabetes highlights limited external validation and calibration
Your Eyes Could Warn You About Heart and Kidney Trouble from Diabetes
This scoping review evaluates artificial intelligence models using fundus photography for patients with Type 2 Diabetes Mellitus. While mode…
This research shows your eye exam might soon do much more than just check your vision.
Frontiers
Apr 23, 2026
Diabetes & Endocrinology
Cohort
Observational Study Evaluating Hospital-Based Chronic Disease Management Platform in Adults With Type 2 Diabetes
Diabetes Control Improves With This Simple Change
This retrospective observational study evaluated adults with type 2 diabetes enrolled in a hospital-based chronic disease management platfor…
It starts with a
Frontiers
Apr 23, 2026
Rheumatology
Sys. Review
Narrative review compares tirzepatide and semaglutide for obesity and type 2 diabetes outcomes.
New Obesity Drug Shows Stronger Weight Loss Than Popular Option
This narrative review evaluates tirzepatide versus semaglutide in individuals with obesity or type 2 diabetes mellitus. The authors synthesi…
This review shows that tirzepatide outperforms semaglutide for weight and blood sugar, but semaglutide currently has stronger proof for prot…
Frontiers
Apr 22, 2026
Nutrition & Obesity Medicine
Meta-analysis
Systematic review suggests resveratrol may improve glycemic control and protect pancreatic beta-cell function in diabetes.
Resveratrol May Protect the Pancreas in Diabetes
This systematic review synthesizes evidence regarding resveratrol in type 2 diabetes and pancreatogenic diabetes. The authors conclude that …
You wake up tired. Again. Your blood sugar is high—despite doing everything "right." You eat well.
Frontiers
Apr 22, 2026
Diabetes & Endocrinology
Cohort
Higher Geriatric Nutritional Risk Index linked to lower osteoporosis risk in diabetic women
Better nutrition linked to lower osteoporosis risk in women with diabetes
This retrospective observational cohort study of 324 postmenopausal women with type 2 diabetes found that a higher Geriatric Nutritional Ris…
A simple nutrition score may help spot osteoporosis risk in women with type 2 diabetes, new hospital data suggests.
Frontiers
Apr 22, 2026
Nutrition & Obesity Medicine
Cohort
Non-traditional lipid indices associate with coronary heart disease risk in MASLD and type 2 diabetes patients.
This blood fat test may spot heart disease risk in diabetics better than standard cholesterol checks
This multicenter retrospective cohort study included 1,823 patients with comorbid metabolic dysfunction-associated steatotic liver disease a…
For people with diabetes and fatty liver, a new set of blood fat numbers could reveal heart risks that standard cholesterol tests often miss…
Frontiers
Apr 22, 2026
Nutrition & Obesity Medicine
Cohort
IGFBP2 as a context-dependent regulator of metabolic dysregulation in obesity and type 2 diabetes
IGFBP2 may signal metabolic changes in obesity and diabetes, but human proof is still missing.
This review examines IGFBP2 as a potential translational indicator of metabolic dysregulation in conditions including obesity, insulin resis…
A protein called IGFBP2 might signal metabolic changes in obesity and diabetes, but human proof is still missing.
Frontiers
Apr 21, 2026
Neurology
Meta-analysis
Systematic review and meta-analysis of oxidative stress biomarkers in older adults with T2DM or Parkinson's disease
Parkinson’s and Diabetes Linked by Hidden Body Damage
This systematic review and meta-analysis evaluated oxidative stress biomarkers in serum, plasma, or leukocytes from 7,521 human subjects age…
Two common diseases may fuel each other through invisible cell damage, making care harder for millions living with both Parkinson's and type…
Apr 20, 2026
Drug Pipeline
Sys. Review
Literature review synthesizes Schisandra chinensis effects on gut microbiota and metabolic pathways across multiple conditions.
This Ancient Berry May Quiet Inflammation From Your Gut to Your Brain
This literature review examines the potential of Schisandra chinensis regarding gut health and metabolic regulation. The authors synthesize …
An ancient berry used for centuries may rebalance gut bacteria to calm inflammation linked to digestive issues, liver disease, diabetes, and…
Frontiers
Apr 19, 2026
Diabetes & Endocrinology
Cohort
SBSPON gene variant rs2291219 linked to higher T2DM risk in Northwest Indian population
A Hidden Gene May Be Quietly Raising Your Type 2 Diabetes Risk
A case-control candidate gene association study in a Northwest Indian population found SBSPON gene expression was significantly higher in in…
A hidden gene linked to higher type 2 diabetes risk may also be shortening the protective caps on DNA inside immune cells, signaling faster …
Frontiers
Apr 18, 2026
Diabetes & Endocrinology
Meta-analysis
Systematic review and meta-analysis of Mendelian randomization studies examining T2DM and cancer associations.
Diabetes Linked to Two Specific Cancers
This systematic review and meta-analysis of Mendelian randomization studies evaluated the association between type 2 diabetes mellitus and s…
Type 2 diabetes raises the risk of pancreatic and endometrial cancers, according to a new analysis of genetic studies.
Frontiers
Apr 16, 2026